|
:: Clinical tests
Avemar assisting in the treatment of cancerous cells including breast cancer, lung cancer, prostate cancer, colon cancer, colorectal cancer, cervical cancer, melanoma, prostate cancer and oral cavity. Avemar treat malignant tumor, immune system disorder and autoimmune diseases.
Significant results shows the effectiveness of Avemar as an adjuvant colorectal cancer and adjuvant breast cancer treatment. Research studies showing significant improvement for patients with metastatic colon cancer, lung cancer, colorectal cancer, melanoma, oral cavity, and those with prostate cancer metastasis, . Thousands of people use Avemar as a breast cancer option treatment.
Clinical trials of Avemar began in the second half of 1995 in Hungary. Later clinics from Israel, Russia, The Czech Republic, Cyprus and Italy also joined the Avemar Research Program. During these clinical trials more than 1200 patients took and/or are taking Avemar. These trials have been conducted according to the standards of GCP (Good Clinical Practice). Data has been analyzed by a committee of independent experts.
Patients with malignant tumors of different types and localization's participated in these clinical tests. Patients with colon cancer, and rectal cancer, carcinoma of the breast cancer, lung cancer, melanoma, neoplasm of the head and neck, tumor of the oral cavity, hematological malignancies, primary liver cancer, urological and childhood cancers were provided with Avemar as a supplement to clinical oncology treatment. |
:: More than 200 scientists are working worldwide (Europe, Asia, North America), using Avemar with standard therapies in immune and autoimmune diseases.
:: Avemar and the Immune System!
Immune and autoimmune diseases effect a very large number of people, many of whom, find very little relief from the range of products currently available.
We believe Avemar offers a new option for many of these people Avemar may help by:
| ~ |
Activating immune mechanisms.
Normalizing the immune regulating system. |
| ~ |
Improving physical condition, performance and quality of life. |
| ~ |
Acting as an antioxidant / free radical scavenger. |
| ~ |
Reducing joint inflammation associated with arthritis. |
| ~ |
Providing Temporary relief of the pain of rheumatoid arthritis and osteoarthritis. |
:: The expected results from using Avemar
| ~ |
Significant prolongation of progression-free period and of complete life span. |
| ~ |
Significant improvement of physical condition and performance. |
| ~ |
Preventing cancer related cachexia. |
| ~ |
Improvement – in certain cases sudden improvement – in quality of life. |
| ~ |
Decreasing the side effects of chemo - and radiotherapy (i.e. damage of the hemopoietic system, post-chemotherapy anemia). |
| ~ |
Widening the applicability of chemotherapeutic treatments. |
| ~ |
Improvement in surgical tolerance, shortening of the postoperative period | |
:: Quality of life
Significant improvement in quality of life (QL score) in patients with advanced lung cancer after treatment with Avemar for at least 4 months. Trial was conducted with the permission of EORTC (European Organization for Research and Treatment of Cancer).
:: Find out how to save money, if you order Avemar now. You can save up to ... |
|
